RT Book, Section A1 Ferreira-González, Ignacio A1 Montori, Victor M. A1 Busse, Jason W. A1 Schünemann, Holger J. A1 Jaeschke, Roman A1 Deveraux, PJ A1 Permanyer-Miralda, Gaietà A1 Guyatt, Gordon A2 Guyatt, Gordon A2 Rennie, Drummond A2 Meade, Maureen O. A2 Cook, Deborah J. SR Print(0) ID 1183876406 T1 Composite End Points T2 Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 978-0-07-179071-0 LK jamaevidence.mhmedical.com/content.aspx?aid=1183876406 RD 2024/10/06 AB CLINICAL SCENARIOYou are an internist seeing a 65-year-old man with stress test–documented angina who—despite taking carefully titrated β-blockers, nitrates, aspirin, an angiotensin-converting enzyme (ACE) inhibitor, and a statin—is substantially restricted in his activities. The patient undergoes coronary angiography, which reveals 3-vessel severe coronary disease. You suggest to him the possibility of surgical revascularization with coronary artery bypass grafting (CABG). The patient expresses reluctance to undergo such an invasive procedure, and he asks if there is a less aggressive approach that might be almost as effective. You consider the possibility of a percutaneous coronary intervention (PCI) as an alternative.